Advertisement

Supportive Care in Cancer

, Volume 19, Issue 9, pp 1471–1472 | Cite as

High doses of oxycodone–naloxone combination may provide poor analgesia

  • Sebastiano MercadanteEmail author
  • Patrizia Ferrera
  • Claudio Adile
Short Communication

Abstract

Several studies have shown that an oxycodone/naloxone combination (ratio 2:1) provides analgesia and less constipation in non-cancer patients receiving relatively low doses of this formulation. A case report of a cancer patient who was receiving increasing doses of oxycodone with an unexpected declining analgesia is presented. The substitution with the same doses (240 mg/day) of regular controlled-release oxycodone was effective in regaining adequate analgesia.

Keywords

Cancer pain Oxycodone Naloxone Constipation 

Notes

Conflict of interest

There are no conflicts of interest.

References

  1. 1.
    Bercovitch M, Adunsky A (2006) High dose controlled-release oxycodone in hospice care. J Pain Palliat Care Pharmacother 20:33–39PubMedGoogle Scholar
  2. 2.
    Hanks GW, and Expert Working group of the Research Network of the European Association for Palliative Care (2001) Morphine and alternative opioids in cancer pain: the EAPC recommendations. Br J Cancer 84:587–593PubMedCrossRefGoogle Scholar
  3. 3.
    Kurz A, Sessler DI (2003) Opioid-induced bowel dysfunction: pathophysiology and potential new therapies. Drugs 63:649–671PubMedCrossRefGoogle Scholar
  4. 4.
    Leppert W (2010) Role of oxycodone and oxycodone/naloxone in cancer pain management. Pharmacol Rep 62:578–591PubMedGoogle Scholar
  5. 5.
    Lowenstein O, Leyendecker P, Lux E, Blagden M et al (2010) Efficacy and safety of combined prolonged-release oxycodone and naloxone in the management of moderate/severe chronic non-malignant pain: results of a prospectively designed pooled analysis of two randomized, double-blind clinical trials. BMC Clin Pharmacol 10:12PubMedCrossRefGoogle Scholar
  6. 6.
    Meissner W, Schmidt U, Hartmann M, Kath R, Reinhart K (2000) Oral naloxone reverses opioid-associated constipation. Pain 84:105–109PubMedCrossRefGoogle Scholar
  7. 7.
    Meissner W, Leyendecker P, Meuller_lissner S, Nadstawek J, Hopp M, Ruckes C (2009) A randomized controlled trial with prolonged-release oral oxycodone and naloxone to prevent and reverse opioid-indued constipation. Eur J Pain 13:56–64PubMedCrossRefGoogle Scholar
  8. 8.
    Mercadante S, Ferrera P, David F, Casuccio A (2011) The use of high doses of oxycodone in an acute palliative care unit. Am J Hosp Palliat Care 28:242–244PubMedCrossRefGoogle Scholar
  9. 9.
    Mueller-Lissner S (2010) Fixed combination of oxycodone with naloxone: a new way to prevent and treat opioid-induced constipation. Adv Ther 27:581–590PubMedCrossRefGoogle Scholar
  10. 10.
    Reid CM, Martin RM, Sterne JA, Davies AN, Hanks GW (2006) Oxycodone for cancer-related pain: meta-analysis of randomized controlled trials. Arch Intern Med 166:837–843PubMedCrossRefGoogle Scholar
  11. 11.
    Sandner-Kiesling A, Leyendecker P, Hopp M, Tarau L, Lejco J et al (2010) Long-term efficacy and safety of combined prolonged-release oxycodone and naloxone in the management of non-cancer chronic pain. Int J Clin Pract 64:763–774PubMedCrossRefGoogle Scholar
  12. 12.
    Simpson K, Keyndecker P, Hopp M, Muller-Lissner S, Lowenstein O et al (2008) Fixed-ratio combination oxycodone/naloxone compared with oxycodone alone for the relief of opioid-induced constipation in moderate-to-severe non cancer pain. Curr Med Res Opin 24:3503–3512PubMedCrossRefGoogle Scholar
  13. 13.
    Smith K, Hopp M, Mundin G, Leyendecker P, Bailey P et al (2008) Single and multiple-dose pharmacokinetic evaluation of oxycodone and naloxone in a opioid agonist/antagonist prolonged-release combination in healthy adult volunteers. Clin Ther 30:2051–2067PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2011

Authors and Affiliations

  • Sebastiano Mercadante
    • 1
    • 2
    Email author
  • Patrizia Ferrera
    • 1
  • Claudio Adile
    • 1
  1. 1.Pain Relief and Palliative Care UnitLa Maddalena Cancer CenterPalermoItaly
  2. 2.Department of Anesthesia and Intensive CareUniversity of PalermoPalermoItaly

Personalised recommendations